Dakota Wealth Management trimmed its position in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 12.9% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 19,614 shares of the company’s stock after selling 2,895 shares during the period. Dakota Wealth Management’s holdings in BlackRock Health Sciences Term Trust were worth $282,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Brown Brothers Harriman & Co. acquired a new position in shares of BlackRock Health Sciences Term Trust in the 3rd quarter worth approximately $32,000. K2 Principal Fund L.P. acquired a new position in BlackRock Health Sciences Term Trust in the third quarter worth $158,000. Jane Street Group LLC bought a new stake in BlackRock Health Sciences Term Trust during the third quarter valued at $357,000. Brown Lisle Cummings Inc. raised its holdings in shares of BlackRock Health Sciences Term Trust by 6.2% during the third quarter. Brown Lisle Cummings Inc. now owns 36,513 shares of the company’s stock worth $578,000 after purchasing an additional 2,128 shares during the period. Finally, Quarry LP lifted its position in shares of BlackRock Health Sciences Term Trust by 304.9% in the 2nd quarter. Quarry LP now owns 98,886 shares of the company’s stock worth $1,519,000 after buying an additional 74,463 shares during the last quarter.
BlackRock Health Sciences Term Trust Stock Down 0.1 %
Shares of NYSE:BMEZ opened at $16.39 on Friday. BlackRock Health Sciences Term Trust has a fifty-two week low of $14.27 and a fifty-two week high of $16.59. The firm has a 50-day simple moving average of $15.29 and a 200 day simple moving average of $15.61.
BlackRock Health Sciences Term Trust Dividend Announcement
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
See Also
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Bloom Energy: Powering the Future With Decentralized Energy
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- Retail Stocks Investing, Explained
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.